Inc ( ) CEO Dwight Egan tells Proactive the molecular diagnostics company has completed the principle design work for a genetic screening test to detect the deadly Wuhan coronavirus.

Egan says the test was developed using the Salt Lake City company’s PCR-based Co-Primer technology, which was recently represented at the International Plant & Animal Genome XXVIII in San Diego.